Project profile — Equitable access to therapeutics

• Africa, regional (45.00%)
• South America, regional (10.00%)
• Asia, regional (40.00%)
• Europe, regional (5.00%)

• Health: COVID-19 control (12264) (100.00%)

• Gender equality (not targeted)
• Environmental sustainability (cross-cutting) (not targeted)
• Participatory development and good governance (not targeted)
• Trade development (not targeted)
• Biodiversity (not targeted)
• Climate change mitigation (not targeted)
• Climate Change Adaptation (not targeted)
• Urban issues (not targeted)
• Desertification (not targeted)
• Children's issues (not targeted)
• Youth Issues (not targeted)
• Disaster Risk Reduction(DRR) (not targeted)
• Indigenous Issues (not targeted)
• Disability (not targeted)
• Nutrition (not targeted)
• ICT as a tool for development (not targeted)

This project supports the Access to COVID-19 Tools Accelerator (ACT-A). It aims to help ensure equitable access to COVID-19 therapeutics, including novel antivirals and medical oxygen in Low-Income Countries (LICs) and Lower-Middle Income Countries (LMICs). Project activities include: (1) coordinating the procurement and delivery of COVID-19 antivirals; and (2) coordinating the procurement, delivery, and installation of medical oxygen facilities and supplies.

The expected outcomes of this project include: (1) increased equitable procurement and delivery of COVID-19 therapeutics; and (2) increased access to medical oxygen facilities and supplies.

The result achieved as of December 2023 through the support of the Canadian government and other international donors includes the provision of novel COVID-19 antivirals, medical oxygen facilities, and supplies to 74 countries.

• Proactive disclosure